SCHEMBL15572548

SCHEMBL15572548

N#CC1=C(N)SC(N)=C(C#N)C1c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CUL4A Q13619 7/20 1.00
ALDH1A1 P00352 13/20 0.68
MEN1 O00255 12/20 0.68
KMT2A Q03164 12/20 0.68
MAPT P10636 11/20 0.68
HSD17B10 Q99714 10/20 0.68
ALOX15 P16050 9/20 0.68
KDM4E B2RXH2 9/20 0.68
BRCA1 P38398 4/20 0.68
ALOX12 P18054 3/20 0.68
USP2 O75604 2/20 0.68
PRNP P04156 1/20 0.68
HPGD P15428 10/20 0.67
HTT P42858 4/20 0.67
TDP1 Q9NUW8 2/20 0.67
LMNA P02545 2/20 0.67
GAA P10253 2/20 0.67
TSHR P16473 2/20 0.67
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15571632 0.79 MEN1 (0.68) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL21043625 0.77 MEN1 (1.00) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL15572874 0.77 MEN1 (0.68) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL15572213 0.74 EEF2K (1.00) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL15572039 0.72 CUL4A (1.00) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL21043628 0.71 CUL4A (1.00) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL7815153 0.71 KDM4E (0.60) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL26121762 0.71 CUL4A (0.54) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL6441000 0.71 KMT2A (0.55) CUL4AALDH1A1MEN1KMT2AMAPT
SCHEMBL13295965 0.69 CUL4A (0.53) CUL4AALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10617683-B2 Inhibitors of CRL4 ubiquitin ligase and uses thereof CORNELL UNIVERSITY (US) 2020-04-14 US claimed
US-20150196546-A1 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF CORNELL UNIVERSITY 2015-07-16 US claimed
EP-2887940-A2 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF Cornell University (US) 2015-07-01 EP claimed
WO-2014031759-A2 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF CORNELL UNIVERSITY (US) 2014-02-27 WO claimed
US-11375716-B2 Acetyl-CoA carboxylase modulators MONSANTO TECHNOLOGY LLC (US) 2022-07-05 US disclosed
CN-104968323-B CRL4 ubiquitin ligase inhibitors and uses thereof 康奈尔大学 2020-08-21 CN disclosed
US-20200214289-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2020-07-09 US disclosed
US-10617683-B2 Inhibitors of CRL4 ubiquitin ligase and uses thereof CORNELL UNIVERSITY (US) 2020-04-14 US disclosed
US-10548313-B2 Acetyl-CoA carboxylase modulators MONSANTO TECHNOLOGY LLC (US) 2020-02-04 US disclosed
EP-2887940-B1 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF UNIV CORNELL (US) 2019-06-05 EP disclosed
US-20180070589-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2018-03-15 US disclosed
US-9844218-B2 Acetyl-CoA carboxylase modulators MONSANTO TECHNOLOGY LLC (US) 2017-12-19 US disclosed
US-20160130229-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2016-05-12 US disclosed
US-20150196546-A1 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF CORNELL UNIVERSITY 2015-07-16 US disclosed
EP-2887940-A2 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF Cornell University (US) 2015-07-01 EP disclosed
WO-2014201326-A1 ACETYL-COA CARBOXYLASE MODULATORS MONSANTO TECHNOLOGY LLC (US) 2014-12-18 WO disclosed
WO-2014031759-A2 INHIBITORS OF CRL4 UBIQUITIN LIGASE AND USES THEREOF CORNELL UNIVERSITY (US) 2014-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130229-A1 ACETYL-COA CARBOXYLASE MODULATORS ACACA, ACACB, ACAT2 CUL4A 857/4885ALDH1A1 1039/4885MEN1 4484/4885
US-11375716-B2 Acetyl-CoA carboxylase modulators ACACA, ACACB, ACAT2 CUL4A 857/4885ALDH1A1 1039/4885MEN1 4484/4885
US-10548313-B2 Acetyl-CoA carboxylase modulators ACACA, ACACB, ACAT2 CUL4A 857/4885ALDH1A1 1039/4885MEN1 4484/4885
US-20200214289-A1 ACETYL-COA CARBOXYLASE MODULATORS ACACA, ACACB, ACAT2 CUL4A 857/4885ALDH1A1 1039/4885MEN1 4484/4885
US-20180070589-A1 ACETYL-COA CARBOXYLASE MODULATORS ACACA, ACACB, ACAT2 CUL4A 857/4885ALDH1A1 1039/4885MEN1 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.